BR0309115A - Composição farmacêutica em pó seco, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, embalagem de medicamento, e, uso de carboidratos derivados particulados em composição farmacêutica em pó seco - Google Patents
Composição farmacêutica em pó seco, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, embalagem de medicamento, e, uso de carboidratos derivados particulados em composição farmacêutica em pó secoInfo
- Publication number
- BR0309115A BR0309115A BR0309115-5A BR0309115A BR0309115A BR 0309115 A BR0309115 A BR 0309115A BR 0309115 A BR0309115 A BR 0309115A BR 0309115 A BR0309115 A BR 0309115A
- Authority
- BR
- Brazil
- Prior art keywords
- dry powder
- pharmaceutical composition
- powder pharmaceutical
- treatment
- inhalation device
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 239000000843 powder Substances 0.000 title abstract 5
- 238000011282 treatment Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title abstract 2
- 150000001719 carbohydrate derivatives Chemical class 0.000 title 1
- 238000009512 pharmaceutical packaging Methods 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0208609.8A GB0208609D0 (en) | 2002-04-13 | 2002-04-13 | Compositions |
| PCT/GB2003/001595 WO2003088944A1 (en) | 2002-04-13 | 2003-04-10 | Dry powder inhalant composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0309115A true BR0309115A (pt) | 2005-02-01 |
Family
ID=9934856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0309115-5A BR0309115A (pt) | 2002-04-13 | 2003-04-10 | Composição farmacêutica em pó seco, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, embalagem de medicamento, e, uso de carboidratos derivados particulados em composição farmacêutica em pó seco |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20050232998A1 (https=) |
| EP (1) | EP1509199A1 (https=) |
| JP (1) | JP2005529874A (https=) |
| KR (1) | KR20040097348A (https=) |
| CN (1) | CN100362986C (https=) |
| AR (1) | AR039408A1 (https=) |
| AU (1) | AU2003224278A1 (https=) |
| BR (1) | BR0309115A (https=) |
| CA (1) | CA2482249A1 (https=) |
| GB (1) | GB0208609D0 (https=) |
| IL (1) | IL164421A0 (https=) |
| IS (1) | IS7501A (https=) |
| MX (1) | MXPA04010082A (https=) |
| NO (1) | NO20044496L (https=) |
| PL (1) | PL373293A1 (https=) |
| RU (1) | RU2004130438A (https=) |
| TW (1) | TW200407174A (https=) |
| WO (1) | WO2003088944A1 (https=) |
| ZA (1) | ZA200408247B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8337816B2 (en) | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
| EP1643974A1 (en) * | 2003-07-11 | 2006-04-12 | Glaxo Group Limited | Inhalable pharmaceutical formulations comprising a sugar ester |
| MX2007009656A (es) | 2005-02-10 | 2007-11-07 | Glaxo Group Ltd | Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma. |
| GB0605723D0 (en) | 2006-03-23 | 2006-05-03 | 3M Innovative Properties Co | Powder filling processes |
| GB0714134D0 (en) * | 2007-07-19 | 2007-08-29 | Norton Healthcare Ltd | Dry-powder medicament |
| BRPI0816278A2 (pt) * | 2007-09-05 | 2015-09-22 | Pfizer Ltd | forma sal |
| TR201007250A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Selobioz içeren formülasyon. |
| TR201007251A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Kalsiyum kanal blokörü formülasyonu. |
| JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
| GB201113662D0 (en) | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
| NZ629438A (en) * | 2012-02-28 | 2016-10-28 | Iceutica Holdings Inc | Inhalable pharmaceutical compositions |
| US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| EP2847207B1 (en) | 2012-05-08 | 2019-03-27 | Nicox Ophthalmics, Inc. | Fluticasone propionate nanocrystals |
| EP2874928B1 (en) | 2012-07-19 | 2016-06-15 | Adamis Pharmaceuticals Corporation | Powder feeding apparatus |
| US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| AU2014261538A1 (en) * | 2013-04-29 | 2015-12-10 | Sanofi Sa | Inhalable pharmaceutical compositions and the inhaler devices containing them |
| CN104644618A (zh) * | 2013-11-19 | 2015-05-27 | 上海医药工业研究院 | 一种干粉吸入剂及其制备方法 |
| EP4218734A1 (en) * | 2014-07-31 | 2023-08-02 | Vectura Inc. | Dry powder formulations for inhalation |
| WO2016052897A1 (en) * | 2014-09-30 | 2016-04-07 | Hanmi Pharm. Co., Ltd. | Dry powder for inhalation formulation having improved stability of combined active ingredients |
| KR20160117069A (ko) * | 2015-03-31 | 2016-10-10 | 한미약품 주식회사 | 복합 활성성분의 안정성이 개선된 흡입용 캡슐제 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR8007911A (pt) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | Inalador aperfeicoado |
| SE448277B (sv) * | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| AU591152B2 (en) * | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| US5202309A (en) * | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
| IL95590A (en) * | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
| GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| PT994887E (pt) * | 1997-07-03 | 2003-04-30 | Elan Drug Delivery Ltd | Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao |
| US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
| UA73965C2 (en) * | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
| GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
| JP2004526674A (ja) * | 2000-12-01 | 2004-09-02 | バテル・メモリアル・インスティテュート | 液体処方物中における生体分子の安定化のための方法 |
| PT1372608E (pt) * | 2001-03-30 | 2008-01-04 | Jagotec Ag | Formulações de aerossol médicas |
| WO2003099764A1 (en) * | 2002-05-28 | 2003-12-04 | Theravance, Inc. | ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS |
-
2002
- 2002-04-13 GB GBGB0208609.8A patent/GB0208609D0/en not_active Ceased
-
2003
- 2003-04-10 CA CA002482249A patent/CA2482249A1/en not_active Abandoned
- 2003-04-10 US US10/510,968 patent/US20050232998A1/en not_active Abandoned
- 2003-04-10 JP JP2003585696A patent/JP2005529874A/ja active Pending
- 2003-04-10 AU AU2003224278A patent/AU2003224278A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001595 patent/WO2003088944A1/en not_active Ceased
- 2003-04-10 KR KR10-2004-7016301A patent/KR20040097348A/ko not_active Withdrawn
- 2003-04-10 RU RU2004130438/15A patent/RU2004130438A/ru not_active Application Discontinuation
- 2003-04-10 CN CNB038134608A patent/CN100362986C/zh not_active Expired - Fee Related
- 2003-04-10 PL PL03373293A patent/PL373293A1/xx unknown
- 2003-04-10 EP EP03720702A patent/EP1509199A1/en not_active Withdrawn
- 2003-04-10 BR BR0309115-5A patent/BR0309115A/pt not_active IP Right Cessation
- 2003-04-10 MX MXPA04010082A patent/MXPA04010082A/es unknown
- 2003-04-11 AR ARP030101279A patent/AR039408A1/es not_active Application Discontinuation
- 2003-04-11 TW TW092108404A patent/TW200407174A/zh unknown
-
2004
- 2004-10-05 IL IL16442104A patent/IL164421A0/xx unknown
- 2004-10-11 IS IS7501A patent/IS7501A/is unknown
- 2004-10-12 ZA ZA200408247A patent/ZA200408247B/xx unknown
- 2004-10-21 NO NO20044496A patent/NO20044496L/no not_active Application Discontinuation
-
2007
- 2007-11-05 US US11/934,983 patent/US20080060645A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1658837A (zh) | 2005-08-24 |
| AR039408A1 (es) | 2005-02-16 |
| US20050232998A1 (en) | 2005-10-20 |
| MXPA04010082A (es) | 2004-12-13 |
| PL373293A1 (en) | 2005-08-22 |
| US20080060645A1 (en) | 2008-03-13 |
| IS7501A (is) | 2004-10-11 |
| IL164421A0 (en) | 2005-12-18 |
| NO20044496L (no) | 2004-11-15 |
| TW200407174A (en) | 2004-05-16 |
| AU2003224278A1 (en) | 2003-11-03 |
| KR20040097348A (ko) | 2004-11-17 |
| JP2005529874A (ja) | 2005-10-06 |
| WO2003088944A1 (en) | 2003-10-30 |
| CN100362986C (zh) | 2008-01-23 |
| GB0208609D0 (en) | 2002-05-22 |
| CA2482249A1 (en) | 2003-10-30 |
| RU2004130438A (ru) | 2005-06-10 |
| ZA200408247B (en) | 2006-03-29 |
| EP1509199A1 (en) | 2005-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309115A (pt) | Composição farmacêutica em pó seco, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, embalagem de medicamento, e, uso de carboidratos derivados particulados em composição farmacêutica em pó seco | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| BR0110139A (pt) | Formulações farmacêuticas para inaladores de pó seco | |
| BR0214806A (pt) | Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno | |
| BR0012351A (pt) | Pós consistindo de partìculas com uma superfìcie perfeitamente macia, para uso como veìculos para a preparação de misturas de inalação com medicamentos micronizados e o método para sua preparação | |
| BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
| FI20002215A0 (fi) | Yhdistelmäpartikkelit | |
| BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
| BR0008276A (pt) | Combinações de formoterol e propionato de fluticasona para asma | |
| TR200101033T2 (tr) | Akış direnci hafifletilmiş, aerosol halindeki aktif maddenin verilmesi | |
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| BG103430A (en) | FACTOR Xa INHIBITING HETEROCYCLIC DERIVATIVES | |
| AR013614A1 (es) | Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento | |
| CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
| BR0309114A (pt) | Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento | |
| DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
| DE69002718D1 (de) | Medikamente. | |
| WO2005041921A3 (en) | Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor | |
| DE60002885D1 (de) | Wässrige formulierung zur nasalen verabreichung | |
| EP1393734A4 (en) | DRUG AGAINST DARMER DISEASES | |
| BRPI0509026A (pt) | formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução | |
| BR0012444A (pt) | Composições de pó seco | |
| WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
| MXPA04012728A (es) | Deshidroepiandrosterona dihidratada y metodos para el tratamiento de asma o una enfermedad pulmonar obstructiva cronica utilizando composiciones de la misma. | |
| DE69918961D1 (de) | Verbesserte inhalationspräparate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE A 8.6 DA RPI 2116 DE 26/07/2011. |